Shopping Cart
- Remove All
- Your shopping cart is currently empty
NLRP3-IN-17 is a potent, selective, and orally active inhibitor of the NLRP3 inflammasome with an IC50 of 7 nM, effectively inhibiting NLRP3-dependent IL-1β secretion in mice, making it valuable for chronic inflammatory disease research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $140 | 5 days |
Description | NLRP3-IN-17 is a potent, selective, and orally active inhibitor of the NLRP3 inflammasome with an IC50 of 7 nM, effectively inhibiting NLRP3-dependent IL-1β secretion in mice, making it valuable for chronic inflammatory disease research [1]. |
Targets&IC50 | NLRP3 inflammasome:7 nM |
In vivo | NLRP3-IN-17 (compound 15) administered orally at 3 mg/kg demonstrated favorable pharmacokinetic (PK) data, with an area under the curve (AUC), half-life (t 1/2), and bioavailability (F%) of 4.2 μg.h/mL, 2.91 h, and 56%, respectively [1]. At a single oral dose of 10 mg/kg, it significantly inhibited NLRP3-dependent IL-1β secretion, reducing IL-1β levels by 44% in an acute in vivo LPS+ATP stimulation model in female C57BL/6 mice [1]. |
Molecular Weight | 394.49 |
Formula | C21H22N4O2S |
Cas No. | 2254432-75-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.